Z-1163-2019 Class II Terminated

Recalled by Integra LifeSciences Corp. — Plainsboro, NJ

FDA device recall Z-1163-2019 was initiated by Integra LifeSciences Corp. on Mar 8, 2019 and is designated Class II. Reason for recall: The Salto Talaris and Integra XT Revision implant labelling was found to list an incorrect metallic coating material symbol on the metallic implant labels (box and inner pouch) and IFU The recall status is terminated (terminated May 15, 2020). Affected quantity: 2029.

Recall details

Product Type
Devices
Report Date
Apr 24, 2019
Initiation Date
Mar 8, 2019
Termination Date
May 15, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2029

Product description

Talar Dome Total Ankle Prosthesis , Flat Cut, Size 2, Left, Product No. LJU822T

Reason for recall

The Salto Talaris and Integra XT Revision implant labelling was found to list an incorrect metallic coating material symbol on the metallic implant labels (box and inner pouch) and IFU

Distribution pattern

Distributors in AL, CA, CT, FL, GA, HI, IA, ID, KS, KY, MD, MI, MO, MT, NC, NE, NJ, NM, NY, OH, OK,PA, TX, VA, WA, and WI.

Code information

180080 182904 183671 184878

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1163-2019
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1163-2019. Report a data issue: hello@regdatalab.com.